Dr. Juan Carlos Jaramillo, MD, is a seasoned Research and Development leader with extensive expertise spanning medical affairs, clinical development, pharmacovigilance, regulatory affairs, market access, and pricing. As Chief Medical Officer at Valneva, he builds on a distinguished career holding senior leadership roles at Daiichi Sankyo, GrĂ¼nenthal, and GSK. With deep experience across diverse pharmaceutical and vaccine sectors, he brings a strong business acumen and a proven track record in advancing prophylactic and therapeutic solutions across global markets.